In-Vitro Toxicology Testing Market Size, Growth

Share on

Global In-Vitro Toxicology Testing Market Analysis - By Product (Assays, Reagents & Labware, Services), Type (ADME, Dose, & Toxic Substance), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (OMICS Technologies, Cell Culture Technology), Method (Cellular Assays, In-Silico Method), Industry (Cosmetics & Household Products, Pharmaceutical), Region – Industry Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: August, 2019

ID: 156

Pages: 180

In-Vitro Toxicology Testing Market Size & Growth (2019 - 2024)

The size of the Global In-Vitro Toxicology Testing Market value is expected to reach USD 35712 Million by 2024 from USD 18418 Million in 2019, growing at a CAGR of 14.16% over the next five years.

In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is very essential in drug discovery as identifies the toxic effects of the new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.

Increasing technological advancements, rising research & development in cell culture, growing demand for in-vitro toxicology tests over the conventional in-vivo tests, increasing awareness towards toxicity testing studies, rising health-consciousness amongst individuals, growing economic status in emerging nations, the existence of favorable regulatory authorities for toxicology testing using the in-vitro tests are driving the growth of in-vitro toxicology testing market.

Synergetic relationships between different stakeholders and an increase in toxicology databases to facilitate the use of in-vitro test methods are regarded to offer essential growth opportunities for the players in the global in-vitro toxicology testing market.

Developing condition-specific makers, tests and increasing demand for IVD products in existing countries provide significant opportunities for the various stakeholders. GEM, which is Growth Engagement Model, aims to create or control the action of working with the clients to establish new opportunities.

However, scarcity of in-vitro models to detect immunostimulation & autoimmunity, lack of predictive ability of in vitro testing over in vivo testing, technological advancements limiting the use & decreasing adoption rate are the major factors that restrain the growth of in-vitro toxicology testing market.

Key happenings in this market in the recent past:

On February 20, 2020, Catalent Inc. the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies and consumer health products, announced its wholly-owned subsidiary, Catalent Pharma Solutions.
On March 27, 2018, BioIVT, a leading provider of biospecimens and related services, announced that it had acquired Ascendance Biotechnology, Inc. which was formed in 2015 from the merger of Hepregen Corporation and the ESI BIO products division of BioTime Inc. to develop a multi-national cell-based company.
On December 28, 2016, Ascendance Biotechnology Inc., a leader in the commercialization of In-Vitro cell-based products and stem-related laboratory products, announced the agreement with GE healthcare providing a right to manufacture, market and sell the GE Healthcare Cytivaof human stem cell-derived and heart muscle cells used for evaluating potential cardiotoxicity.
On December 06, 2015, BioTime Inc. regenerative medicine company, and Hepregen Corporation, announced the formation of Ascendance Biotechnology Inc. Ascendance combines Hepregen’s application –directed, cellular micro-patterning drug and chemical screening technologies with BioTime’s ESI BIO research products and proprietary stem cell-based technologies.
On January 31, 2012, Sigma-Aldrich, a leading Life Science and High Technology company, announced that it had completed its acquisition of Bio reliance Holdings Inc., a leading provider of biopharmaceutical testing services, from Avista Capital Partners.

REPORT COVERAGE

REPORT METRIC	DETAILS
Market Size Available	2018 – 2024
Base Year	2018
Forecast Period	2019 - 2024
Segments Covered	By Product, Type, Toxicity End points and tests, Method, Technology, Industry, Region
Various Analyses Covered	Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
Regions Covered	North America, Europe, APAC, Latin America, Middle East & Africa
Market Leaders Profiled	Covance, Inc. (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.)

This market research report on Global Waste Sorting Robots Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.

In-Vitro Toxicology Testing Market Analysis – By Product

Assays
Reagents & Labware
Services
Growth Hormone Therapy

On the basis of product, the Assays segment is estimated to command the largest share of the global in-vitro toxicology testing market by product in 2018.

In-Vitro Toxicology Testing Market Analysis – By Type

ADME (Absorption, Distribution, Metabolism, and Excretion)
Dose
Toxic Substance

In-Vitro Toxicology Testing Market Analysis – By Toxicity Endpoints & Tests

Systemic Toxicity
Dermal Toxicity
Carcinogenicity
Ocular Toxicity
Skin Sensitization & Irritation
Genotoxicity
Neurotoxicity
Organ Toxicity
Other Toxicity Endpoints & Tests

On the basis of Toxicity Endpoints & Tests, Systemic toxicity is estimated to command the largest share of the global in-vitro toxicology testing market by toxicity endpoints & tests in 2016. Technology is further segmented into OMICS technologies & cell culture technology.

In-Vitro Toxicology Testing Market Analysis – By Technology

OMICS Technologies
Cell Culture Technology
High-Throughput Technologies
Molecular Imaging Technologies

In-Vitro Toxicology Testing Market Analysis – By Method

In-Silico Methods
Biochemical Assays
Cellular Assays
Ex-Vivo Models

On the basis of method, the In-silico method is estimated to command the largest share of the global in-vitro toxicology testing market by the method in 2018.

In-Vitro Toxicology Testing Market Analysis – By Industry

Cosmetics and Household Products
Diagnostics
Pharmaceuticals
Food Industry
Chemicals

On the basis of industry, the cosmetics & household products industry is estimated to account for the largest market share of the global in-vitro toxicology testing market by industry in 2018.

Regional Analysis:

Europe is estimated to account for the largest share of 32.5% of the global in-vitro toxicology testing market in 2018, whereas Asia-Pacific is estimated to grow at the highest CAGR of 16.10% during the forecast period.

Top companies in the Global In-Vitro Toxicology Testing Market

The key players in global in-vitro toxicology testing market include Covance, Inc. (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.), among others.

Introduction
1. Market Definition
2. Study Deliverables
3. Base Currency, Base Year and Forecast Periods
4. General Study Assumptions
Research Methodology
1. Introduction
2. Research Phases
  1. Secondary Research
  2. Primary Research
  3. Econometric Modelling
  4. Expert Validation
3. Analysis Design
4. Study Timeline
Overview
1. Executive Summary
2. Key Inferences
3. New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
1. Market Drivers
2. Market Restraints
3. Key Challenges
4. Current Opportunities in the Market
Market Segmentation
1. Product
  1. Introduction
  2. Assays
  3. Reagents & Labware
  4. Services Growth Hormone Therapy
2. Type
  1. Introduction
  2. ADME (Absorption, Distribution, Metabolism, and Excretion)
  3. Dose
  4. Toxic Substance
3. Toxicity Endpoints & Tests
  1. Introduction
  2. Systemic Toxicity
  3. Dermal Toxicity
  4. Carcinogenicity
  5. Ocular Toxicity
  6. Skin Sensitization & Irritation
  7. Genotoxicity
  8. Neurotoxicity
  9. Organ Toxicity
  10. Other Toxicity Endpoints & Tests
4. Technology
  1. Introduction
  2. OMICS Technologies
  3. Cell Culture Technology
  4. High-Throughput Technologies
  5. Molecular Imaging Technologies
5. Method
  1. Introduction
  2. In-Silico Methods
  3. Biochemical Assays
  4. Cellular Assays
  5. Ex-Vivo Models
6. Industry
  1. Introduction
  2. Cosmetics and Household Products
  3. Diagnostics
  4. Pharmaceuticals
  5. Food Industry
  6. Chemicals
Geographical Analysis
1. North America
  1. Introduction
  2. United States
  3. Canada
2. Europe
  1. Introduction
  2. U K
  3. Spain
  4. Germany
  5. Italy
  6. France
3. Asia-Pacific
  1. Introduction
  2. China
  3. India
  4. Japan
4. Latin America
  1. Introduction
  2. Brazil
  3. Rest of Latin America
5. Middle East & Africa
  1. Introduction
  2. Middle-East
  3. South Africa
  4. Rest of Middle East & Africa
Strategic Analysis
1. PESTLE analysis
  1. Political
  2. Economic
  3. Social
  4. Technological
  5. Legal
  6. Environmental
2. Porter’s Five analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Consumers
  3. Threat of New Entrants
  4. Threat of Substitute Products and Services
  5. Competitive Rivalry within the Industry
Market Leaders' Analysis
1. Covance, Inc (A subsidiary of LabCorp) (U S )
  1. Overview
  2. Product Analysis
  3. Strategic Evaluation and Operations
  4. Financial analysis
  5. Legal issues
  6. Recent Developments
  7. SWOT analysis
  8. Analyst View
2. Agilent Technologies, Inc (U S )
3. Bio-Rad Laboratories, Inc (U S )
4. Eurofins Scientific SE (Luxembourg)
5. General Electric Company (U S )
6. BioReliance, Inc (U S )
7. Charles River Laboratories International, Inc (U S )
8. Thermo Fisher Scientific, Inc (U S )
9. Catalent (U S )
10. Cyprotex (U K )
Competitive Landscape
1. Market share analysis
2. Merger and Acquisition Analysis
3. Agreements, collaborations and Joint Ventures
4. New Product Launches
Expert Opinions
1. Market Outlook
2. Investment Opportunities
Appendix
1. List of Tables
2. List of Figures

Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Please go for the sample to get access to the List of Figures and Tables of the report.

Please wait. . . . Your request is being processed

Related Reports

North America In-Vitro Toxicology Testing Market

North America In-Vitro Toxicology Testing market is poised to reach USD 10214 Million by 2024. The countries here are US, Canada, Mexico and Rest of North America

Aug 2019

Download Sample

Europe In-Vitro Toxicology Testing Market

Europe In-Vitro Toxicology Testing market is poised to reach USD 10735 Million by 2024. The countries here are UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe.

Aug 2019

Download Sample

APAC In-Vitro Toxicology Testing Market

Asia Pacific in-vitro toxicology testing market is poised to reach USD 7073 Million by 2024. The countries here are India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC.

Aug 2019

Download Sample

Latin America In-Vitro Toxicology Testing Market

Latin America in-vitro toxicology testing market is poised to reach USD 3210 Million by 2024. The countries here are Brazil, Argentina, Chile and Rest of Latin America.

Aug 2019

Download Sample

MEA In-Vitro Toxicology Testing Market

Middle East and Africa in-vitro toxicology testing market is poised to reach USD 5096 Million by 2024. The countries here are KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Aug 2019

Download Sample